Ascendis Pharma A/S (NASDAQ:ASND) Q4 2024 Earnings Call Transcript February 12, 2025
Ascendis Pharma A/S beats earnings expectations. Reported EPS is $-0.68699, expectations were $-1.32.
Operator: Good day and thank you for standing by. Welcome to the Fourth Quarter and Full Year 2024 Ascendis Pharma Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions]...
